Objectives: Detection of adverse drug events (ADEs) in Danish hospitals relies on health care professionals' incident reporting to a national database for adverse events, but the method is incomplete; thus, fatal and life-threatening ADEs may remain unrecognized.The objectives of this study were to examine the occurrence of life-threatening and fatal ADEs in population of hospitalized patients with suspected adverse outcome and to compare these findings with the actual number of reported ADEs in the study period of 3 months.
Methods: Study was designed as a cross-sectional study of adult population, hospitalized for more than 24 hours, having an unplanned transfer to an intensive care unit (ICU), or having unexpected death. Medical records were retrospectively screened by the Global Trigger Tool. All positive triggers were assessed for ADEs by a clinical pharmacologist.
Results: Of the 26,176 patients admitted in the study period, 105 had an unplanned transfer to the ICU and 36 died unexpectedly. In total, 15 positive triggers were identified in 10 patients. Life-threatening ADEs accounted for 7.6% (8/105) of patients transferred to the ICU, and fatal ADEs constituted 5.5% (2/36) of the deceased patients. Life-threatening and fatal ADEs corresponded to an overall prevalence of 0.04% (10/26,176). Most ADEs were related to hemorrhages and respiratory problems. No serious or fatal ADEs were reported in the incident reporting system in the study period.
Conclusions: Ten life-threatening and fatal ADEs were uncovered as not reported in the incident reporting system. Further steps are needed for recognition and prevention of this patient safety challenge.
Adverse drug events in an intensive care unit of a university hospital.Eur J Clin Pharmacol. 2011 Jun;67(6):625-32. doi: 10.1007/s00228-010-0987-y. Epub 2011 Jan 19. Eur J Clin Pharmacol. 2011. PMID: 21246350
Adverse drug events caused by serious medication administration errors.BMJ Qual Saf. 2012 Nov;21(11):933-8. doi: 10.1136/bmjqs-2012-000946. Epub 2012 Jul 12. BMJ Qual Saf. 2012. PMID: 22791691 Free PMC article.
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.JAMA. 1995 Jul 5;274(1):29-34. JAMA. 1995. PMID: 7791255
Pilot testing of checklists to discern adverse drug reactions and adverse drug events.J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):61-9. doi: 10.1331/JAPhA.2013.11196. J Am Pharm Assoc (2003). 2013. PMID: 23636158 Review.
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.Health Qual Life Outcomes. 2011 Sep 29;9:83. doi: 10.1186/1477-7525-9-83. Health Qual Life Outcomes. 2011. PMID: 21958008 Free PMC article. Review.
Cited by 1 article
Drug change: 'a hassle like no other'. An in-depth investigation using the Danish patient safety database and focus group interviews with Danish hospital personnel.Ther Adv Drug Saf. 2019 Jul 12;10:2042098619859995. doi: 10.1177/2042098619859995. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31321023 Free PMC article.